TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.94
+8.10%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 907.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 660.51x
- Price / sales
- —
- Price / cash flow
- -105.00x
Enterprise value
- Enterprise value
- $449.5M
- EV / sales
- —
- EV / EBITDA
- -107.87x
- EV / EBIT
- -64.39x
- Market cap
- $453.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026